Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1202579013 | Candesartan cilexetil + hydrochlorothiazide 16mg/12.5mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1215479013 | Candesartan cilexetil + hydrochlorothiazide 16mg/12.5mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1478634018 | Candesartan cilexetil+hydrochlorothiazide 16mg/12.5mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3490422014 | Product containing candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3494226015 | Product containing candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3501618012 | Candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3569184013 | Product containing only candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569185014 | Product containing only candesartan cilexetil 16 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3677239013 | Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3677240010 | Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Is a | Product containing hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Is a | Product containing candesartan | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Is a | Product containing candesartan cilexetil | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has active ingredient | Candesartan cilexetil | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Is a | Product containing candesartan cilexetil and hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Is a | Product containing hydrochlorothiazide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has basis of strength substance | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 12.5 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has active ingredient | Candesartan cilexetil | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has basis of strength substance | Candesartan cilexetil | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 16 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has precise active ingredient | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has precise active ingredient | Candesartan cilexetil | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Is a | Product containing candesartan and hydrochlorothiazide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Is a | Product containing only candesartan and hydrochlorothiazide in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Plays role | Diuretic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has precise active ingredient | Hydrochlorothiazide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has basis of strength substance | Hydrochlorothiazide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has basis of strength substance | Candesartan cilexetil | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely candesartan cilexetil 16 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet | Has precise active ingredient | Candesartan cilexetil | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR